the genotoxic and hepatotoxic potential of Ace-k were confirmed ... The upregulation of P53 in the liver was correlated with increased polyploidization and necro apoptotic reaction.
In rats, the genotoxic and hepatotoxic potential of acesulfame-K was confirmed - a dose-dependent increase in comet-assay tail moment and hepatic P53 upregulation correlated with polyploidization and a necro-apoptotic reaction.
Ace-K consumption perturbed the gut microbiome of CD-1 mice after a 4-week treatment. ... ace-K increased body weight gain of male but not female mice.
In CD-1 mice, four weeks of acesulfame-K consumption perturbed the gut microbiome and increased body-weight gain in males (but not females), with sex-specific shifts in bacterial composition.
Exhibit 03ReassuranceInformational
The acceptable daily intake (ADI) considered safe for all population groups was set at 15 mg/kg body weight (bw) per day. ... the highest exposure estimate of E 950 was generally below the ADI in all population groups, indicating no safety concern.
EFSA's 2025 re-evaluation of acesulfame K (E 950) set an ADI of 15 mg/kg bw/day, considered safe for all population groups, with the highest EU exposure estimates generally below the ADI - indicating no safety concern.
Exhibit 04ReassuranceInformational
the agency has concluded that the high-intensity sweeteners approved by FDA are safe for the general population under certain conditions of use.
The FDA has concluded that the high-intensity sweeteners it has approved - including acesulfame potassium (Ace-K) - are safe for the general population under certain conditions of use.